1. CREB3 protein family: the promising therapeutic targets for cardiovascular and metabolic diseases.
- Author
-
Gao YP, Hu C, Hu M, Dong WS, Li K, Ye YJ, Hu YX, and Zhang X
- Subjects
- Humans, Animals, Lipid Metabolism, Molecular Targeted Therapy, Inflammation metabolism, Cardiovascular Diseases metabolism, Cardiovascular Diseases drug therapy, Metabolic Diseases metabolism, Metabolic Diseases drug therapy, Cyclic AMP Response Element-Binding Protein metabolism
- Abstract
Significant advancements in cardiovascular and metabolic disease research have been made with the CREB3 protein family. Studies have revealed that members of this family are crucial in the development of these diseases, contributing to the regulation of lipid metabolism, inflammation, and vascular function. These studies provide useful information for future therapeutic strategies in cardiovascular and metabolic diseases., Competing Interests: Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF